Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland (Швейцария) 2 School of Psychology, Universidad NacionalAutonoma de Mexico, Mexico City, Mexico (Мексика) 3 Department of Psychiatry, New York Medical College, New York, NY, USA (США) 4 Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York State Psychiatric Institute and New York Presbyterian Hospital, New York, NY, USA (США) 5 Primary Care and Public Health Directorate, Ministry of Health, Manama, Bahrain; 6 Fielding School of Public Health, University of California, Los Angeles, CA, USA (США) 7 Department of Medical Psychology, VU University Medical Centre, and Center of Expertise on Gender Dysphoria, Amsterdam, The Netherlands (Нидерланды) 8 InstitutoNacional de Psiquiatria Ramon de la Fuente Muniz, Mexico City, Mexico (Мексика) 9 Departments of Medicine and Psychiatry, Weill Cornell Medical College and New York Presbyterian Hospital/Westchester Division, White Plains, NY, USA (США) 10 Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland (Швейцария) 11 Institute for Sex Research and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Германия)
Список исп. литературыСкрыть список
1. International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders. A conceptual framework for the revision of the ICD-10 classiﬁcation of mental and behavioural disorders. World Psychiatry 2011;10:86-92.
2. First MB, Reed GM, Hyman SE et al. The development of the ICD-11 clinical descriptions and diagnostic guidelines for mental and behavioural disorders. World Psychiatry 2015;14:82-90.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
4. World Health Organization. The ICD-10 classiﬁcation of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
5. Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med 2009;6:629:32.
6. Lewis RW, Fugl-Meyer KS, Corona G et al. Deﬁnitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010;7:1598-607.
7. McCabe MP, Sharlip ID, Atalla E et al. Deﬁnitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:135-43.
8. McCabe MP, Sharlip ID, Lewis R et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:15367.
9. Carvalho J, Nobre P. Biopsychosocial determinants of men’s sexual desire: testing an integrative model. J Sex Med 2011;8:754-63.
10. Chou D, Cottler S, Khosla R et al. Sexual health in the International Classiﬁcation of Diseases (ICD): implications for measurement and beyond. Reprod Health Matters 2015;23:185-92.
11. World Health Organization. International statistical classiﬁcation of diseases and related health problems, 10th revision (ICD-10). Geneva: World Health Organization, 1992.
12. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
13. Kingsberg SA, Clayton AH, Pfaus JG. The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of Hypoactive Sexual Desire Disorder. CNS Drugs 2015;29:915-33.
14. Basson R. The female sexual response: a different model. J Sex Marital Ther 2000;26:51-65.
15. Hackett G, Krychman M, Baldwin D et al. Coronary heart disease, diabetes, and sexuality in men. J Sex Med 2016;13:887-904.
16. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med 2012;9:1497-507.
17. El Miedany Y, El Gaafary M, El Aroussy N et al. Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. ClinRheumatol 2012; 31:601-6.
18. Mohammadi K, Rahnama P, Mohseni SM et al. Determinants of sexual dysfunction in women with multiple sclerosis. BMC Neurol 2013;13:83.
19. Catania L, Abdulcadir O, Puppo V et al. Pleasure and orgasm in women with female genital mutilation/cutting (FGM/C). J Sex Med 2007;4:166678.
20. Johnson SD, Phelps D, Cottler LB. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav 2004;33:55-63.
21. Clayton AH, Croft HA, Handiwala L. Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med 2014;126:91-9.
22. Nobre PJ, Pinto-Gouveia J. Dysfunctional sexual beliefs as vulnerability factors to sexual dysfunction. J Sex Res 2006;43:68-75.
23. Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross
sectional populations survey. J Epidemiol Community Health 1999;53:1448.
24. Oberg K, Fugl-Meyer KS, Fugl-Meyer AR. On sexual well being in sexually abused Swedish women: epidemiological aspects. Sex Relation Ther 2002;17:329-41.
25. Brotto LA, Atallah S, Johnson-Agbakwu C et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2016; 13:538-71.
26. Laumann EO, Nicolosi A, Glasser DB et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identiﬁed in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17: 39-57.
27. Atallah S, Johnson-Agbakwu C, Rosenbaum T et al. Ethical and sociocultural aspects of sexual function and dysfunction in both sexes. J Sex Med 2016;13:591-606.
28. Oniz A, Keskinoglu P, Bezircioglu I. The prevalence and causes of sexual problems among premenopausal Turkish women. J Sex Med 2007;4: 1575-81.
29. Laan E, Rellini AH, Barnes T. Standard operating procedures for female orgasmic disorder: consensus of the International Society for Sexual Medicine. J Sex Med 2013;10:74-82.
30. Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav 2010;39:221-39.
31. Parish SJ, Hahn SR. Hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment. Sex Med Rev 2016;4: 103-20.
32. DeRogatis LR, Clayton AH, Rosen RC et al. Should sexual desire and arousal disorders in women be merged? Arch Sex Behav 2011;40:217-9.
33. Sungur MZ, G€und€uz A. A comparison of DSM-IV-TR and DSM-5 deﬁnitions for sexual dysfunctions: critiques and challenges. J Sex Med 2014; 11:364-73.
34. Sarin S, Amsel RM, Binik YM. Disentangling desire and arousal: a classiﬁcatory conundrum. Arch Sex Behav 2013;42:1079-100.
35. Balon R, Clayton AH. Female sexual interest/arousal disorder: a diagnosis out of thin air. Arch Sex Behav 2014;43:1227-9.
36. Burri A, Greven C, Leupi M et al. A multivariate twin study of female sexual dysfunction. J Sex Med 2012;9:2671-81.
37. Bishop JR, Moline J, Ellingrod VL et al. Serotonin 2A-1438 G/A andGprotein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology 2006;31:2281-8.
38. Bishop JR, Ellingrod VL, Akroush M et al. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol 2009;24:207-15.
39. Arnow BA, Millheiser L, Garrett A et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. Neuroscience 2009;158:484-502.
40. Pyke RE, Clayton AH. Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective. J Sex Med 2015;12:2451-8.
41. Berman JR, Berman LA, Toler SM et al. Safety and efﬁcacy of sildenaﬁl citrate for the treatment of female sexual arousal disorder: a doubleblind, placebo controlled study. J Urology 2003;170:2333-8.
42. Brotto LA, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med 2008;5:1646-59.
43. Brotto LA, Chivers ML, Millman RD et al. Mindfulness-based sex therapy improves genital-subjective arousal concordance in women with sexual desire/arousal difﬁculties. Arch Sex Behav (in press).
44. Maserejian NN, Shifren J, Parish SJ et al. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary ﬁndings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther 2012;38:41-62. 45. Binik YM. Should dyspareunia be retained as a sexual dysfunction in DSM-V? A painful classiﬁcation. Arch Sex Behav 2005;34:11-21.
46. Pukall CF, Goldstein AT, Bergeron S et al. Vulvodynia: deﬁnition, prevalence, impact, and pathophysiological factors. J Sex Med 2016;13:291304.
47. Bornstein J, Goldstein AT, Stockdale CK et al. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classiﬁcation of persistent vulvar pain and vulvodynia. J Sex Med 2016;127:745-51.
48. Segraves RT. Considerations for a better deﬁnition of male orgasmic disorder in DSM V. J Sex Med 2010;7:690-9.
49. Waldinger M. Male ejaculation and orgasm disorders. In: Balon R, Segraves R (eds). Handbook of sexual dysfunction. Boca Raton: Taylor and Francis, 2005:215-48.
50. Wylie K, Ralph D, Levin RJ et al. Comments on “Considerations for a better deﬁnition of male orgasmic disorder in DSM V”. J Sex Med 2010;7: 695-9.
51. Global Action for Trans* Equality. It’s time for reform. Trans health issues in the International Classiﬁcation of Diseases. Report on the GATE Experts Meeting. The Hague, November 2011.
52. European Commission. Trans and intersex people: discrimination on the grounds of sex, gender identity and gender expression. Luxembourg: European Union, 2012.
53. European Parliament. Resolution of 28 September 2011 on human rights, sexual orientation and gender identity at the United Nations. Strasbourg: European Parliament, 2011.
54. World Health Organization. Mental health action plan 2013-2020. Geneva: World Health Organization, 2013.
55. World Health Organization. Basic documents, 48th ed. Geneva: World Health Organization, 2014.
56. United Nations High Commissioner for Human Rights. Discriminatory laws and practices and acts of violence against individuals based on their sexual orientation and gender identity. New York: United Nations General Assembly, 2011.
57. Council of Europe. Discrimination on grounds of sexual orientation and gender identity in Europe, 2nd ed. Strasbourg: Council of Europe Publishing, 2011.
58. World Health Organization. Sexual health, human rights and the law. Geneva: World Health Organization, 2015.
59. World Professional Association for Transgender Health. Standards of care for the health of transsexual, transgender and gender non-conforming people, version 7.World Professional Association for Transgender Health, 2011.
60. United Nations Development Programme. Discussion paper: Transgender health and human rights. New York: United Nations Development Programme, 2013.
61. Sood N. Transgender people’s access to sexual health and rights: a study of law and policy in 12 Asian countries. Kuala Lumpur: Asian-Paciﬁc Resource and Research Centre for Women, 2009.
62. Nuttbrock L, Hwahng S, Bockting W et al. Psychiatric impact of genderrelated abuse across the life course of male-to-female transgender persons. J Sex Res 2010;47:12-23.
63. Grossman AH, D’Augelli AR. Transgender youth: invisible and vulnerable. J Homosex 2006;51:111-28.
64. Sugano E, Nemoto T, Operario D. The impact of exposure to transphobia on HIVrisk behavior in a sample of transgendered women of color in San Francisco. AIDS Behav 2006;10:217-25.
65. Grossman AH, D’Augelli AR, Salter NP. Male-to-female transgender youth: gender expression milestones, gender atypicality, victimization, and parents’responses. J GLBT Fam Stud 2006;2:71-92.
66. Rotondi NK, Bauer GR, Scanlon K et al. Nonprescribed hormone use and self-performed surgeries: “do-it-yourself” transitions in transgender communities in Ontario, Canada. Am J Public Health 2013;103:1830-6.
67. Sanchez NF, Sanchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health 2009;99:713-9.
68. Asscheman H, Giltay EJ, Megens JA et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.Eur J Endocrinol 2011;164:635-42.
69. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J ClinEndocrinolMetab 2009;94:3132-54.
70. Mueller A, Gooren L. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 2008;159:197-202.
71. Robles R, Fresan A, Vega-Ramırez H et al. Removing transgender identity from the classiﬁcation of mental disorders: a Mexican ﬁeld study for ICD-11. Lancet Psychiatry 2016;3:850-9.
72. Drescher J, Cohen-Kettenis P, Winter S. Minding the body: situating gender identity diagnoses in the ICD-11. Int Rev Psychiatry 2012;24:568-77.
73. Drescher J, Cohen-Kettenis PT, Reed GM. Gender incongruence of childhood in the ICD-11: controversies, proposal, and rationale. Lancet Psychiatry 2016;3:297-304.
74. Lo S, Horton R. Transgender health: an opportunity for global health equity. Lancet 2016;388:316-8.
75. Reisner SL, Poteat T. Keatley J et al. Global health burden and needs of transgender populations: a review. Lancet 2016;388:412-36.
76. Winter S, Settle E, Wylie K et al. Synergies in health and human rights: a call to action to improve transgender health. Lancet 2016;388:318-21.
77. Cabral M, Suess A, Ehrt J et al. Removal of gender incongruence of childhood diagnostic category: a human rights perspective. Lancet Psychiatry 2016;3:405-6.
78. Drescher J, Byne W. Gender dysphoric/gender variant (GD/GV) children and adolescents: summarizing what we know and what we have yet to learn. J Homosex 2012;59:501-10.
79. Drescher J, Byne W. Treating transgender children and adolescents: an interdisciplinary discussion. New York: Routledge, 2013.
80. Steensma TD, McGuire JK, Kreukels BP et al. Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. J Am Acad Child Adolesc Psychiatry 2013;52:582-90.
81. Steensma TD, Biemond R, de Boer F et al. Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 2011;16:499-516. 82. Byne W, Bradley SJ, Coleman E, et al. Report of the APA Task Force on Treatment of Gender Identity Disorder. Arch Sex Behav 2012;41:759-96.
83. Bouman WP, Bauer GR, Richards C et al. World Professional Association for Transgender Health consensus statement on considerations of the role of distress (Criterion D) in the DSM diagnosis of gender identity disorder. Int J Transgend 2010;12:100-6.
84. Ehrbar RD, Witty MC, Ehrbar HG et al. Clinician judgment in the diagnosis of gender identity disorder in children. J Sex Marital Ther 2008;34:385412.
85. Joyal CC. How anomalous are paraphilic interests? Arch Sex Behav 2014; 43:1241-3. 86. Joyal CC. Deﬁning “normophilic” and “paraphilic” sexual fantasies in a population-based sample: on the importance of considering subgroups. Sex Med 2015;3:321-30.
87. Richters J, de Visser RO, Rissel CE et al. Demographic and psychosocial features of participants in bondage and discipline, “sadomasochism” or dominance and submission (BDSM): data from a national survey. J Sex Med 2008;5:1660-8.
88. Reiersøl O, Skeid S. The ICD diagnoses of fetishism and sadomasochism. J Homosex 2006;50:243-62.
89. Cochran SD, Drescher J, Kism€odi E et al. Proposed declassiﬁcation of disease categories related to sexual orientation in the International Statistical Classiﬁcation of Diseases and Related Health Problems (ICD-11). Bull World Health Organ 2014;92:672-9. 90. Krueger RB, Reed GM, First MB et al. Paraphilic disorders in the International Classiﬁcation of Disease and Related Health Problems, Eleventh Revision (ICD-11). Arch Sex Behav (in press).
91. Briken P, Fedoroff JP, Bradford JW. Why can’t pedophilic disorder remit? Arch Sex Behav 2014;43:1237-9.
92. Becker JV, Stinson J, Tromp S et al. Characteristics of individuals petitioned for civil commitment. Int J Offend Ther 2003;47:185-95.
93. Berner W, Berger P, Hill A. Sexual sadism. Int J Offend Ther 2003;47:38395.
94. Briken P, Bourget D, Dufour M. Sexual sadism in sexual offenders and sexually motivated homicide. PsychiatrClin North Am 2014;37:215-30.
95. Elwood RW, Doren DM, Thornton D. Diagnostic and risk proﬁles of men detained under Wisconsin’s sexually violent person law. Int J Offend Ther 2010;54:187-96.
96. Packard, RL, Levenson JL. Revisiting the reliability of diagnostic decisions in sex offender civil commitment. Sexual Offender Treatment 2006;1:115.
97. Krueger RB. The DSM diagnostic criteria for sexual sadism. Arch Sex Behav 2010;39:325-45.
98. Abel GG, Becker JV, Mittelman M et al. Self-reported sex crimes of nonincarceratedparaphiliacs. J Interpers Violence 1987;2:3-25.
99. Ahlers CJ, Schaefer GA, Mundt IA et al. How unusual are the contents of paraphilias? Paraphilia-associated sexual arousal patterns in a communitybased sample of men. J Sex Med 2011;8:1362-70.
100. Bradford JMW, Boulet J, Pawlak A. The paraphilias: a multiplicity of deviant behaviors. Can J Psychiatry 1992;37:104-8.
101. La ˚ngstr€om N. The DSM diagnostic criteria for exhibitionism, voyeurism, and frotteurism. Arch Sex Behav 2010;39:317-24.
102. Templeman TL, Stinnett RD. Patterns of sexual arousal and history in a “normal” sample of young men. Arch Sex Behav 1991;20,137-50.
103. Johnson RS, Ostermeyer B, Sikes KA et al. Prevalence and treatment of frotteurism in the community: a systematic review. J Am Acad Psychiatry Law 2014;42:478-83.
104. Nordic Centre for Classiﬁcations in Health Care. Removed ICD-10 codes in categories F64 and F65 in the Nordic Countries. Helsinki: Nordic Centre for Classiﬁcations in Health Care, 2015.
105. First MB, Halon RL. Use of DSM paraphilia diagnoses in sexually violent predator commitment cases. J Am Acad Psychiatry Law 2008;36:443-54.
106. US Supreme Court. Kansas v. Hendricks, 521 U.S. 346 (1997).
107. Janus E. Sexually violent predator laws: psychiatry in service to a morally dubious enterprise. Lancet 2004;364:50-1.
108. Zonana H. The civil commitment of sex offenders. Science 1997;278:1248-9.
109. First MB. DSM-5 and paraphilic disorders. J Am Acad Psychiatry Law 2014;42:191-201. 110. O’Flaherty M, Fisher J. Sexual orientation, gender identity and international human rights law: contextualising the Yogyakarta Principles. Human Rights Law Rev 2008;8:207-48.
111. Caceres CF, Konda K, Segura ER et al. Epidemiology of male same-sex behaviour and associated sexual health indicators in low- and middleincome countries: 2003-2007 estimates. Sex Transm Infect 2008;84(Suppl. 1):i49-56.
112. Hooker E. Reﬂections of a 40-year exploration: a scientiﬁc view on homosexuality. Am Psychol 1993;48:450-3.
113. Drescher J. Queer diagnoses: parallels and contrasts in the history of homosexuality, gender variance, and the Diagnostic and Statistical Manual. Arch Sex Behav 2010;39:427-60.
114. King M, McKeown E, Warner J et al. Mental health and quality of life of gay men and lesbians in England and Wales: controlled, cross-sectional study. Br J Psychiatry 2003;183:552-8.
115. Mays VM, Cochran SD. Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. Am J Public Health 2001;91:1869-76. 116. Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull 2003;129:674-97.
117. Organization for Security and Cooperation in Europe/Ofﬁce for Democratic Institutions and Human Rights. Hate crimes in the OSCE region – incidents and responses. Annual report for 2006. Warsaw: Organization for Security and Cooperation in Europe/Ofﬁce for Democratic Institutions and Human Rights, 2007.
118. Calzo JP, Antonucci TC, Mays VM et al. Retrospective recall of sexual orientation identity development among gay, lesbian, and bisexual adults. DevPsychol 2011;47:1658-73.
119. Spitzer RL. The diagnostic status of homosexuality in DSM-III: a reformulation of the issues. Am J Psychiatry 1981;138:210-5.
120. van Drimmelen-Krabbe JJ, Ustun TB, Thompson DH et al. Homosexuality in the International Classiﬁcation of Diseases: a clariﬁcation. JAMA 1994; 272:1660.
121. American Psychological Association. Guidelines for psychological practice with lesbian, gay, and bisexual clients. Am Psychol 2012;67:10-42.
122. Pan American Health Organization.“Cures” for an illness that does not exist. Washington, DC: Pan American Health Organization, 2012.
123. Reed GM, First MB, Medina-Mora ME et al. Draft diagnostic guidelines for ICD-11 mental and behavioural disorders available for review and comment. World Psychiatry 2016;15:112-3.
Поделиться ссылкой на выделенное